 |
 
|
Asia's largest stem cells and regenerative medicine industry conference
Overview
World Stem Cells & Regenerative Medicine Congress Asia 2013 brings together leading pharmas, biotechs, regulators, research institutes and investors from Asia. It is an unrivalled platform to learn about Asia's stem cell industry.
Co-located with 6th Annual BioPharma Asia Convention 2013, which is the largest and most strategic biopharmaceutical industry gathering, the event brings together more than 4,000 stakeholders and decision makers from all across the globe to discuss partnership ideas, business trends and investment opportunites in Asia's biopharma sector.
Who attends
- Principal Scientists
- Heads of Regenerative Medicine
- Heads of Therapeutic Stem Cells
- Heads of Toxicology
- Chairman
- Presidents
- CEOs
From pharmas, biotechs and research institutes
Reasons to attend
- Gain insights into Asia's stem cell industry from leading pharmas, biotechs and research institutes
- Identify and assess the critical issues at the interface of stem cells and regenerative medicine
- Uncover the latest breakthroughs in the stem cell industry in Asia
- Engage in meaningful discussions with Asia's industry veterans and global heavyweights
- Learn about the up and coming technologies to fast track your stem cell development in Asia
Testimonials
"The speaker presentations covered a wide breadth of disciplines in the field and were very interesting. I was further pleased to make many potential new business links." ~Richard Mollard, Head of Stem Cells, Respiratory Development and Tissue Engineering Group, Monash University
"The conference provides a good opportunity for collaboration between basic research scientists and pharmaceutical companies. I want to recommend this conference to colleagues and scientists in the future."~ Dong Wook Kim, Director, Korea Stem Cell Research Center
Partnering app "live"
With our new event app and portal, you can now plan which sessions to attend, identify exhibitors you want to see and pre-arrange one to one meetings with other attendees.
Zhong Zhong, Ph.D. currently Senior Director of Regenerative Medicine Discovery at GlaxoSmithKline R&D, and has been Senior Director of Discovery Technology of GSK’s R&D Center in Shanghai for the past four year and played a key role in discovering drug leads fo…more ›
Education: -Bachelor in mechanical engineering from Egypt, Masters in mechanical engineering from The Netherlands/Egypt, and a PhD in Aerospace and Mechanical Engineering from University of Arizona. Cardiology fellow, University of Arizona College of Medicine (Tucson VA…more ›
Dr. Keyoung has more than 15 years of healthcare and life sciences experience through his role as scientist, surgeon, consultant and investor. At Burrill & Company, Dr. Keyoung is Managing Director and Head of Pan-Asia. Dr. Keyoung is Managing Director of Burrill’s …more ›
Ms Ma has been an advisor to TVM Capital since late 2004 and joined TVM Capital as Venture Partner for life sciences in 2007. She entered the life sciences industry in 2000 when she was a Senior Vice President at Vertex Management, where she co-led the Global Biotechno…more ›
Dr. Deans is responsible for regenerative medicine technology development at Athersys Inc. and its European subsidiary, ReGenesys. Athersys is developing cell therapeutics based on adherent stem cells (MultiStem) isolated from adult bone marrow. Athersys has active Ph…more ›
